MLACX
Price
$4.49
Change
-$0.05 (-1.10%)
Updated
Jun 13 closing price
Net Assets
13.45B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

MLACX vs RGEBX

Header iconMLACX vs RGEBX Comparison
Open Charts MLACX vs RGEBXBanner chart's image
NYLI Winslow Large Cap Growth
Price$4.49
Change-$0.05 (-1.10%)
VolumeN/A
Net Assets13.45B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
MLACX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLACX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLACX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. MLACX (13.5B). MLACX (0.00) and RGEBX (0.00) have matching dividends . MLACX was incepted earlier than RGEBX: MLACX (20 years) vs RGEBX (11 years). MLACX (1.89) is less costly to investors than RGEBX (1.09). MLACX is a more actively managed with annual turnover of: 70.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MLACX: RGEBX (250) vs MLACX (1000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. MLACX (-22.59). RGEBX return over 5 years is better than : 45.42 vs. MLACX (-39.49).
MLACXRGEBXMLACX / RGEBX
Total Expense Ratio1.881.09172%
Annual Report Gross Expense Ratio1.891.09173%
Fund Existence20 years11 years-
Gain YTD4.6624.82997%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets13.5B306B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year-22.597.68-294%
Returns for 3 years-11.7951.01-23%
Returns for 5 years-39.4945.42-87%
Returns for 10 years-52.9465.87-80%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd